Affluent Medical enters strategic collaboration with Edwards Lifesciences for Kalios ring

Affluent Medical signed a cooperation agreement with Edwards Lifesciences covering an exclusive option on Kalios technology, a non-exclusive license for mitral valve replacement IP, and an equity stake. Edwards will pay a total of €15 million in prepayments.

“We are proud to sign these agreements with the global leader in structural heart innovation.”vcbeathealth.com

• 1 source
• vcbeathealth.comAffluence Medical Enters Strategic Collaboration with Edwards Lifesciences for Kalios Adjustable Mitral Annuloplasty Ring-VCBeatJul 13, 2024

Summarized from public sources; check the original articles before acting on it.